Mind Medicine (MindMed) Inc.
NASDAQ:MNMD
7.32 (USD) • At close December 24, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Mind Medicine (MindMed) Inc. |
Symbool | MNMD |
Munteenheid | USD |
Prijs | 7.32 |
Beurswaarde | 536,787,942 |
Dividendpercentage | 0% |
52-weken bereik | 3.49 - 12.22 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Robert Barrow |
Website | https://www.mindmed.co |
An error occurred while fetching data.
Over Mind Medicine (MindMed) Inc.
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. The company develops MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder, as well as for the
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)